Arcadium Lithium Releases Fourth Quarter and Full Year 2024 Results
PHILADELPHIA and PERTH, Australia, Feb. 28, 2025 /PRNewswire/ -- Arcadium Lithium plc (NYSE: ALTM, ASX: LTM, "Arcadium Lithium" or the "Company") today reported results for the fourth quarter and full year of 2024. As a result of its pending...
New Canopus SEER Platform Gives Ultimate Control over Data Powering AI Agents
Agentic-AI, real-time network observability platform with programmable sensors and curated data streams enables network teams to see every user and application experience in Ultra-HD clarity SAN JOSE, Calif., Feb. 28, 2025 /PRNewswire/ -- Canopus...
Databricks Achieves FedRAMP High Authorization for AWS GovCloud
Hires industry veteran Mike Daniels to lead public sector practice amid rapidly growing demand for data intelligence SAN FRANCISCO, Feb. 27, 2025 /PRNewswire/ -- Amid the growing momentum of its Public Sector business, Databricks, the Data and AI...
DXC Names Former COO at Federal Reserve, Pat McClanahan, as Global Leader of Business and Sales Operations for Consulting & Engineering Services
ASHBURN, Va., Feb. 27, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Pat McClanahan as Global Leader of Business and Sales Operations for Consulting...
DXC Technology Promotes Jennifer Ragone to Chief People Officer
ASHBURN, Va., Feb. 27, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Jennifer Ragone as Chief People Officer. Ragone will report directly to DXC...
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
SUZHOU, China, Feb. 27, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III...
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
WUXI, China, Feb. 27, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's...
AIM Vaccine's mRNA RSV Vaccine Approved for U.S. Clinical Trials
Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) HONG KONG, Feb. 27, 2025 /PRNewswire/ -- The...
GameChange Solar's Genius Tracker™ Racking Verified Compatible by Intertek for 2kV Solar Projects
Trackers successfully deployed in Southeastern US pilot project NORWALK, Conn., Feb. 27, 2025 /PRNewswire/ -- GameChange Solar (GCS), a leading global supplier of solar tracker and fixed-tilt racking technology, announced that its Genius Tracker™...
Tuya Reports Fourth Quarter and Fiscal 2024 Unaudited Financial Results and Declaration of Dividend
SANTA CLARA, Calif., Feb. 26, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced its unaudited financial results for the fourth quarter and fiscal...